Hyundai Bioscience Co., Ltd. (KOSDAQ:048410)
South Korea · Delayed Price · Currency is KRW 10,520
-470 (-4.28%)
May 20, 2026, 3:30 PM KST
Hyundai Bioscience Market Cap
Hyundai Bioscience has a market cap or net worth of 1.02 trillion as of May 20, 2026. Its market cap has increased by 90.47% in one year.
Market Cap
1.02T
Enterprise Value
992.92B
Revenue
3.52B
Ranking
n/a
PE Ratio
n/a
Stock Price
10,520.00
Market Cap Chart
Since March 3, 2003, Hyundai Bioscience's market cap has increased from 47.49B to 1.02T, an increase of 2,037.56%. That is a compound annual growth rate of 14.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 1.02T | 112.91% |
| Dec 30, 2025 | 476.83B | -15.13% |
| Dec 30, 2024 | 561.85B | -45.92% |
| Dec 28, 2023 | 1.04T | -4.44% |
| Dec 29, 2022 | 1.09T | 11.39% |
| Dec 30, 2021 | 976.10B | -6.92% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 65.69T |
| Celltrion | 39.57T |
| ALTEOGEN | 19.75T |
| Samsung Epis Holdings | 12.62T |
| Chong Kun Dang Pharmaceutical | 1.07T |
| Pharmicell | 1.03T |
| DongKook Pharmaceutical | 1.02T |
| SD Biosensor | 947.77B |